Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387458075> ?p ?o ?g. }
- W4387458075 endingPage "2435" @default.
- W4387458075 startingPage "2435" @default.
- W4387458075 abstract "Uncontrolled inflammation is a pathological state that underlies many diseases. Despite the development of numerous anti-inflammatory agents, the treatment of uncontrolled inflammation remains a challenging task. We developed a targeted delivery system for [5-(p-fluorophenyl)-2-ureido]thiophene-3-carboxamide (TPCA-1), a potent inhibitor of the NF-κB signaling pathway. The system comprises TPCA-1-loaded nanoparticles (NPs) functionalized with a monoclonal antibody (mAb) that specifically binds to the break point of the IgD6 region of the platelet/endothelial cell adhesion molecule-1 (PECAM-1) extracellular segment that is overexposed on the injured endothelium and activated macrophages during the pathogenesis of inflammation. In vitro binding and cellular uptake experiments revealed that the mAb modification on NPs could significantly enhance uptake by both Raw264.7 and HUVEC compared with unmodified NPs. In studies conducted at the cellular level focusing on anti-inflammatory and antioxidant effects, this formulation was found to effectively inhibit M1 polarization of macrophages, downregulate the secretion of pro-inflammatory cytokines, and reduce the production of reactive oxygen species (ROS) and nitric oxide (NO). In an animal model of vascular endothelial injury with acute inflammation, these NPs were capable of delivering TPCA-1 to inflammatory lesions in a targeted manner. Compared with the free agent-treated group, the NP-treated group exhibited reduced infiltration of inflammatory cells. In conclusion, our study demonstrates that this targeted delivery of TPCA-1-loaded NPs represents a promising strategy for improved mitigation of uncontrolled inflammation." @default.
- W4387458075 created "2023-10-10" @default.
- W4387458075 creator A5036547657 @default.
- W4387458075 creator A5044870711 @default.
- W4387458075 creator A5048815633 @default.
- W4387458075 creator A5062638981 @default.
- W4387458075 creator A5065775543 @default.
- W4387458075 creator A5079286679 @default.
- W4387458075 creator A5080506792 @default.
- W4387458075 creator A5084388409 @default.
- W4387458075 creator A5089186571 @default.
- W4387458075 date "2023-10-09" @default.
- W4387458075 modified "2023-10-11" @default.
- W4387458075 title "Enhancing the Treatment of Uncontrolled Inflammation through the Targeted Delivery of TPCA-1-Loaded Nanoparticles" @default.
- W4387458075 cites W1861735138 @default.
- W4387458075 cites W1981147276 @default.
- W4387458075 cites W1982687474 @default.
- W4387458075 cites W2043260924 @default.
- W4387458075 cites W2045018547 @default.
- W4387458075 cites W2050622829 @default.
- W4387458075 cites W2055583156 @default.
- W4387458075 cites W2061235037 @default.
- W4387458075 cites W2081477919 @default.
- W4387458075 cites W2094393090 @default.
- W4387458075 cites W2097558357 @default.
- W4387458075 cites W2144728675 @default.
- W4387458075 cites W2148357124 @default.
- W4387458075 cites W2171526199 @default.
- W4387458075 cites W2317982666 @default.
- W4387458075 cites W2333055410 @default.
- W4387458075 cites W2396212074 @default.
- W4387458075 cites W2405919788 @default.
- W4387458075 cites W2444143487 @default.
- W4387458075 cites W2624985846 @default.
- W4387458075 cites W2763425528 @default.
- W4387458075 cites W2765948467 @default.
- W4387458075 cites W2768087563 @default.
- W4387458075 cites W2780527762 @default.
- W4387458075 cites W2782685575 @default.
- W4387458075 cites W2810667939 @default.
- W4387458075 cites W2886380636 @default.
- W4387458075 cites W2904286341 @default.
- W4387458075 cites W2904751900 @default.
- W4387458075 cites W2941857484 @default.
- W4387458075 cites W3008170328 @default.
- W4387458075 cites W3013522609 @default.
- W4387458075 cites W3014663601 @default.
- W4387458075 cites W3016924203 @default.
- W4387458075 cites W3018463525 @default.
- W4387458075 cites W3021915688 @default.
- W4387458075 cites W3026849454 @default.
- W4387458075 cites W3041595964 @default.
- W4387458075 cites W3047096870 @default.
- W4387458075 cites W3096513322 @default.
- W4387458075 cites W3156568050 @default.
- W4387458075 cites W3159758537 @default.
- W4387458075 cites W3160385542 @default.
- W4387458075 cites W3205030329 @default.
- W4387458075 cites W3206059837 @default.
- W4387458075 cites W3208645787 @default.
- W4387458075 cites W3211580616 @default.
- W4387458075 cites W4200626544 @default.
- W4387458075 cites W4210379203 @default.
- W4387458075 cites W4210642183 @default.
- W4387458075 cites W4213245349 @default.
- W4387458075 cites W4224979410 @default.
- W4387458075 cites W4226055319 @default.
- W4387458075 cites W4236162659 @default.
- W4387458075 cites W4281683632 @default.
- W4387458075 cites W4284692560 @default.
- W4387458075 cites W4293681097 @default.
- W4387458075 cites W4307263614 @default.
- W4387458075 cites W4308767683 @default.
- W4387458075 cites W4318826585 @default.
- W4387458075 cites W4386609992 @default.
- W4387458075 doi "https://doi.org/10.3390/pharmaceutics15102435" @default.
- W4387458075 hasPublicationYear "2023" @default.
- W4387458075 type Work @default.
- W4387458075 citedByCount "0" @default.
- W4387458075 crossrefType "journal-article" @default.
- W4387458075 hasAuthorship W4387458075A5036547657 @default.
- W4387458075 hasAuthorship W4387458075A5044870711 @default.
- W4387458075 hasAuthorship W4387458075A5048815633 @default.
- W4387458075 hasAuthorship W4387458075A5062638981 @default.
- W4387458075 hasAuthorship W4387458075A5065775543 @default.
- W4387458075 hasAuthorship W4387458075A5079286679 @default.
- W4387458075 hasAuthorship W4387458075A5080506792 @default.
- W4387458075 hasAuthorship W4387458075A5084388409 @default.
- W4387458075 hasAuthorship W4387458075A5089186571 @default.
- W4387458075 hasBestOaLocation W43874580751 @default.
- W4387458075 hasConcept C178790620 @default.
- W4387458075 hasConcept C185592680 @default.
- W4387458075 hasConcept C203014093 @default.
- W4387458075 hasConcept C2776914184 @default.
- W4387458075 hasConcept C2781184567 @default.
- W4387458075 hasConcept C502942594 @default.
- W4387458075 hasConcept C519581460 @default.
- W4387458075 hasConcept C71924100 @default.